Crossmark

SIRT4 inhibits malignancy progression of NSCLCs, through mitochondrial dynamics mediated by the ERK-Drp1 pathway

Published Online: 2016-12-12

Published Print: 2017-05-11

Authors

Fu, L

Dong, Q

He, J

Wang, X

Xing, J

Wang, E

Qiu, X

Li, Q
License Information

Text and Data Mining valid from 2016-12-12

Version of Record valid from 2016-12-12
More Information

Article History

Received: 31 October 2015

Revised: 19 September 2016

Accepted: 10 October 2016

First Online: 12 December 2016

Competing interests

: The authors declare no conflict of interest.

Document is current